Parker Geoffrey M. sold ALLO

Source

Document

SEC Form 4

Publisher

U.S. Securities and Exchange Commission (EDGAR)

Document ID

0001491874-26-000005

Machine-readable

Structured copy

Timestamps

Event (reported)

Oct 21, 2026

Published

Oct 23, 2026

Ingested by INSIDER

Nov 5, 02:09 UTC

Last re-read

Nov 5, 02:09 UTC

Extracted facts

Filer

Parker Geoffrey M.

Role

CHIEF FINANCIAL OFFICER

Transaction

Open-market saleAs filed: “S”

Asset

Allogene Therapeutics, Inc.

Ticker

ALLO

Shares

36.3K

Price per share

$1.34

Value

$48,698

Execution date (reported)

Oct 21, 2026

Owned after transaction

1.05M shares

Days from execution to publication

2

Calculation

What this establishes

Parker Geoffrey M. filed this Form 4 reporting a open-market sale of ALLO on Oct 21, 2026. It became public on Oct 23, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

Extraction

Method

Form 4 XML

Confidence

1.00

CHIEF FINANCIAL OFFICER

Parker Geoffrey M.cik:0001491874

Issuer

Allogene Therapeutics, Inc.cik:0001737287

Revision history · 0

No field has changed since this record was first ingested.